Andere Sprachen Vera Therapeutics, Inc.

Aktien

A3CPQG

US92337R1014

VERA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 14.05.2024			% 5 Tage	% 1. Jan.
40,87 ^USD	+0,29 %		-9,18 %	+165,73 %

10.05.	VERA THERAPEUTICS, INC. : Wedbush klebt neutral	ZM
09.05.	Vera Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	09.05.
Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K	09.05.
Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	07.05.
Wall Street herstelt na rentevrees	11.04.
Wall Street koerst overwegend hoger	11.04.
Wall Street koerst af op vlakke opening	11.04.
Futures wijzen op lagere opening Wall Street	11.04.
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11.04.
Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition	10.04.
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress	02.04.
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress	02.04.
Certain Restricted Stock Units of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29.03.
Certain Stock Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29.03.
Certain Class A common stock of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29.03.
Sector Update: Health Care Stocks Steady Premarket Wednesday	20.03.
Vera Therapeutics' 2023 Loss Narrows	20.03.
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	20.03.
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	20.03.
Vera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vera Therapeutics, Inc.

Aktien

A3CPQG

US92337R1014

VERA

Andere Sprachen

Filter